Application 208230
- Type
- ANDA
- Sponsor
- AVET LIFESCIENCES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEOSTIGMINE METHYSULFATE | NEOSTIGMINE METHYLSULFATE | SOLUTION;INTRAVENOUS | 5MG/10ML (0.5MG/ML) | No | No |
| 002 | NEOSTIGMINE METHYSULFATE | NEOSTIGMINE METHYLSULFATE | SOLUTION;INTRAVENOUS | 10MG/10ML (1MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208230-001 | NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | |
| A208230-002 | NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208230-001 | AP |
| A208230-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A208230-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A208230-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A208230-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A208230-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A208230-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A208230-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208230-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208230-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208230-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208230-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208230-001 | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208230-002 | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A208230-001 | NEOSTIGMINE METHYSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | A208230-002 | NEOSTIGMINE METHYSULFATE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-11-25 | ea1830bbd6c7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A208230-001 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A208230-002 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A208230-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A208230-002 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A208230-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A208230-002 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A208230-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A208230-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208230-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208230-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208230-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A208230-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208230-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208230-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208230-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208230-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208230-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208230-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208230-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208230-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208230-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208230-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208230-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208230-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A208230-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A208230-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208230-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208230-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208230-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208230-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208230-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208230-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A208230-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A208230-002 | AP | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208230-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208230-002 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A208230-001 | AP | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A208230-002 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A208230-001 | AP | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A208230-002 | AP | 1 | ea1830bbd6c7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Hikma Pharmaceuticals USA Inc. | 7a9d996f-aecb-455f-95fc-1010e461d75d | 2026-03-18 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine methylsulfate | NEOSTIGMINE METHYLSULFATE | ProPharma Distribution | 3857462f-2d3c-bada-e063-6294a90a7438 | 2025-07-18 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | Indoco Remedies Limited | 6657402f-1db2-411e-bf66-fca3902756c4 | 2025-03-18 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Civica, Inc. | 454d54dc-b803-4519-81e8-ac7d21e6aae1 | 2024-12-26 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Fresenius Kabi USA, LLC | d0e11e4c-41c3-4874-b567-579db655fba3 | 2024-10-15 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | Eugia US LLC | c5729883-88d7-40fe-8fe4-fe39204ccb30 | 2024-08-29 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine methylsulfate | NEOSTIGMINE METHYLSULFATE | Amneal Pharmaceuticals LLC | 856c3775-8925-4bd5-a93d-604829e73440 | 2024-06-30 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Hikma Pharmaceuticals USA Inc. | 28365ed5-8332-48ac-a93d-b165ac3c6eac | 2024-04-10 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Hikma Pharmaceuticals USA Inc. | f6b466a7-817c-4cb6-ac58-1b3bbf0531df | 2024-04-09 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | Medical Purchasing Solutions, LLC | 12f25113-bf55-cee7-e063-6294a90a9d56 | 2024-03-05 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Dr.Reddys Laboratories Inc | 12575d1a-a2c2-37b2-0dcf-31e58bbc2a10 | 2024-02-07 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | HF Acquisition Co LLC, DBA HealthFirst | c4be8467-7b7e-551d-e053-2995a90a3045 | 2024-01-30 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Fresenius Kabi USA, LLC | 088f96eb-20b8-48f8-ac83-329f75a44ce1 | 2024-01-22 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Fresenius Kabi USA, LLC | b0b509c3-8dc8-48cc-b7a8-16b93ad706c6 | 2024-01-01 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Bloxiverz | NEOSTIGMINE METHYLSULFATE | Exela Pharma Sciences, LLC | d2f55643-2b0d-4ef9-a9d8-b7138b314372 | 2023-12-31 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | Amphastar Pharmaceuticals, Inc. | e47a4a4c-0e7c-40b6-9950-5b3adadcac22 | 2023-06-01 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | Medical Purchasing Solutions, LLC | 6b541714-9850-bdbd-e053-2991aa0ab244 | 2023-06-01 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE METHYLSULFATE | Medical Purchasing Solutions, LLC | 7978e3c0-6ee3-6db5-e053-2991aa0a2d33 | 2023-05-16 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Medical Purchasing Solutions, LLC | ea6027ca-aac5-c33a-e053-2995a90a87fc | 2023-05-03 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
| Neostigmine Methylsulfate | NEOSTIGMINE METHYLSULFATE | Fresenius Kabi USA, LLC | 6448229c-e650-47ba-bb00-cba3604502c5 | 2022-12-13 | Warnings, Adverse reactions | NEOSTIGMINE METHYLSULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 23155-517 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | Current |
| 23155-518 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | Current |